Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep and neuropathic pain: Sleep structure in neuropathic pain patients
2020-001957-31Phase 4Active
- Sponsor
- Eija Kalso
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of pregabalin in Neuralgia, sponsored by Eija Kalso. Primary endpoint: Mean pain interference during previous week. Started Jun 2021; status: active.
02
Drugs
pregabalin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2020-001957-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001957-31.